• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Rogers Corporation

Rogers Corporation

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile

    Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile

  2. Roxgold extends QV1 mineralization at Bagassi South and announces additional results from its development infill drilling on the 55 Zone

    Roxgold extends QV1 mineralization at Bagassi South and announces additional results from its development infill drilling on the 55 Zone

  3. Roxgold reports financial results for period ended March 31, 2015

    Roxgold reports financial results for period ended March 31, 2015

  4. Roche Receives FDA Approval for cobas® KRAS Mutation Test

    Roche Receives FDA Approval for cobas® KRAS Mutation Test

  5. Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

    Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

  6. New Cancer Drugs: First Movers Will Win

    First movers, including Bristol-Myers, and firms that can aggregate a portfolio of immuno-oncology therapies will be positioned well.

  7. Wide-Moat Funds That Fly Under the Radar

    These quality funds with smaller asset bases have portfolios built around solid companies.

  8. Dodge & Cox: Pharma Stocks Showing Value

    As incomes rise, emerging-markets consumers can afford more and better medications driving attractive growth in the pharmaceuticals sector, say the managers of Dodge & Cox International Stock.

  9. Funds Betting on Big Pharma

    Large drugmakers are out of favor, but some good funds are banking on a rebound.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.